ATRC
AtriCure Inc
58.40$
-3.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.1% | 43.4% | 41.4% | 42.3% | 43.8% | 44.0% | 42.5% | 44.6% | 47.4% | 49.3% | 48.7% | 51.1% | |
| 13.4% | 13.7% | 11.0% | 17.8% | 21.2% | 20.1% | 16.9% | 19.3% | 23.3% | 25.6% | 22.7% | 24.8% | |
| 22.2% | 22.4% | 17.9% | 19.1% | 21.2% | 20.1% | 16.9% | 19.3% | 23.3% | 25.6% | 22.7% | 24.8% | |
| 8.6% | 8.6% | 9.4% | 9.3% | 8.9% | 9.9% | 10.7% | 10.8% | 9.9% | 10.2% | 11.1% | 11.8% | |
| 10.3% | 11.1% | 12.2% | 12.3% | 12.4% | 12.4% | 12.7% | 12.5% | 12.4% | 12.0% | 12.6% | 12.4% | |
| 39.1% | 38.2% | 39.7% | 39.3% | 38.2% | 38.5% | 39.7% | 38.6% | 36.9% | 35.9% | 36.5% | 34.7% | |
| 10.9% | 10.4% | 10.5% | 10.1% | 9.5% | 9.3% | 9.2% | 8.6% | 7.9% | 7.3% | 7.1% | 41.1% | |
| 22.9% | 24.1% | 22.9% | 22.6% | 24.4% | 24.3% | 23.2% | 23.7% | 25.0% | 24.8% | 23.6% | 23.7% | |
| 13.8% | 12.1% | 10.4% | 10.3% | 12.1% | 12.0% | 10.3% | 11.3% | 12.2% | 12.5% | 11.4% | 12.1% | |
| 3.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | – | |
| 4.1% | 4.5% | 4.9% | 4.5% | 5.2% | 4.1% | 4.3% | 4.2% | 4.0% | 12.0% | 4.7% | 11.6% | |
| 7.0% | 9.9% | 10.5% | 10.4% | 10.1% | 10.2% | 10.5% | 10.2% | 9.7% | 9.5% | 9.5% | 9.0% | |
| 77.1% | 75.9% | 77.1% | 77.4% | 75.6% | 75.7% | 76.8% | 76.3% | 75.0% | 75.2% | 76.4% | 76.3% | |
| -57.9% | -58.2% | -62.6% | -63.3% | -62.8% | -65.9% | -69.0% | -68.1% | -65.3% | -63.2% | -64.1% | -59.7% | |
| 7.7% | 7.6% | 7.9% | 7.9% | 7.7% | 7.7% | 8.0% | 7.8% | 7.5% | 7.5% | 7.6% | 7.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.